Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2204]

European Commission approves nivolumab for first-line and previously-treated advanced melanoma patients

European Commission approves nivolumab for first-line and previously-treated advanced melanoma patients

NICE reject enzalutamide for advanced prostate cancer before chemotherapy

NICE reject enzalutamide for advanced prostate cancer before chemotherapy

Rolling submission of Biologic License Application initiated for daratumumab with US FDA for multiple myeloma

Rolling submission of Biologic License Application initiated for daratumumab with US FDA for multiple myeloma

Oral cancer therapy combination prevents progression of advanced melanoma for over a year

Oral cancer therapy combination prevents progression of advanced melanoma for over a year

Challenges ahead for European clinical trials

Challenges ahead for European clinical trials

Trabectedin improves disease control in patients with advanced soft tissue sarcoma

Trabectedin improves disease control in patients with advanced soft tissue sarcoma

$European Commission grants marketing authorization for lenvatinib in advanced RAI-refractory differentiated thyroid cancer$

European Commission grants marketing authorization for lenvatinib in advanced RAI-refractory differentiated...

NICE preliminary decision to remove olaparib for ovarian cancer patients with BRCA gene mutations

NICE preliminary decision to remove olaparib for ovarian cancer patients with BRCA gene mutations

Positive CHMP opinion recommends ibrutinib for the treatment of Waldenström’s macroglobulinemia

Positive CHMP opinion recommends ibrutinib for the treatment of Waldenström’s macroglobulinemia

Morocco joins the International Agency for Research on Cancer

Morocco joins the International Agency for Research on Cancer

More from ecancer